Genadi Iosava

2.8k total citations
9 papers, 297 citations indexed

About

Genadi Iosava is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Genadi Iosava has authored 9 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Genetics and 1 paper in Surgery. Recurrent topics in Genadi Iosava's work include Hemophilia Treatment and Research (5 papers), Platelet Disorders and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Genadi Iosava is often cited by papers focused on Hemophilia Treatment and Research (5 papers), Platelet Disorders and Treatments (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Genadi Iosava collaborates with scholars based in United States, Lebanon and Russia. Genadi Iosava's co-authors include Diethelm Messinger, Anders Österborg, Michael Hedenus, Abdulkadyrov Km, Yvonne Brandberg, Claudia Djambas Khayat, Oleksandra Stasyshyn, Alex Veldman, Kathelijn Fischer and Nicole Blackman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Thrombosis and Haemostasis.

In The Last Decade

Genadi Iosava

8 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Genadi Iosava United States	6	248	82	75	53	43	9	297
Shashikant Apte India	9	146 0.6×	19 0.2×	43 0.6×	20 0.4×	6 0.1×	31	198
Kerry Taylor Australia	11	328 1.3×	14 0.2×	260 3.5×	21 0.4×	21 0.5×	23	373
Oriana López‐Godino Spain	8	104 0.4×	42 0.5×	16 0.2×	2 0.0×	32 0.7×	16	184
Cathy G. Rosenfield United States	6	317 1.3×	14 0.2×	96 1.3×	14 0.3×	20 0.5×	11	381
Emöke Deschmann Sweden	6	96 0.4×	3 0.0×	22 0.3×	33 0.6×	39 0.9×	9	172
Merih Kızıl Çakar Türkiye	7	67 0.3×	33 0.4×	32 0.4×	2 0.0×	17 0.4×	40	125
C. Murphy Ireland	6	118 0.5×	5 0.1×	137 1.8×	12 0.2×	17 0.4×	11	208
Mahmoud Elsawy United States	7	190 0.8×	62 0.8×	62 0.8×	1 0.0×	29 0.7×	15	244
Berntorp Sweden	7	231 0.9×	11 0.1×	91 1.2×	5 0.1×	3 0.1×	8	278
Ann Birner United States	6	93 0.4×	63 0.8×	191 2.5×	1 0.0×	32 0.7×	14	304

Countries citing papers authored by Genadi Iosava

Since Specialization

Citations

This map shows the geographic impact of Genadi Iosava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genadi Iosava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genadi Iosava more than expected).

Fields of papers citing papers by Genadi Iosava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genadi Iosava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genadi Iosava. The network helps show where Genadi Iosava may publish in the future.

Co-authorship network of co-authors of Genadi Iosava

This figure shows the co-authorship network connecting the top 25 collaborators of Genadi Iosava. A scholar is included among the top collaborators of Genadi Iosava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genadi Iosava. Genadi Iosava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Mahlangu, Johnny, Howard Levy, Marina Kosinova, et al.. (2021). Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety. Research and Practice in Thrombosis and Haemostasis. 5(6). e12576–e12576. 12 indexed citations

Khayat, Claudia Djambas, et al.. (2021). Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients. Journal of Blood Medicine. Volume 12. 483–495. 1 indexed citations

Auerswald, G., Claudia Djambas Khayat, Oleksandra Stasyshyn, et al.. (2020). <p>Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)</p>. Journal of Blood Medicine. Volume 11. 213–225. 6 indexed citations

Grosicki, Sebastian, Genadi Iosava, Mamia Zodelava, et al.. (2020). An Open Label, Phase 2 Study to Assess the Efficacy and Safety of Tenalisib (RP6530), a PI3K δ/γ and SIK3 Inhibitor, in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL). Blood. 136(Supplement 1). 25–25. 1 indexed citations

Stasyshyn, Oleksandra, Claudia Djambas Khayat, Genadi Iosava, et al.. (2017). Safety, efficacy and pharmacokinetics of rVIII‐SingleChain in children with severe hemophilia A: results of a multicenter clinical trial. Journal of Thrombosis and Haemostasis. 15(4). 636–644. 30 indexed citations

Evatt, Bruce L., et al.. (2005). National haemophilia programme development in the Republic of Georgia. Haemophilia. 11(5). 529–534. 5 indexed citations

Furman, Richard R., Genadi Iosava, Luis Isola, et al.. (2005). Forodesine (FodosineTM), a PNP Inhibitor Active in Relapsed or Refractory T-Cell Leukemia Patients (Phase II Study).. Blood. 106(11). 881–881. 6 indexed citations

Österborg, Anders, Yvonne Brandberg, Genadi Iosava, et al.. (2002). Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Human Erythropoietin, Epoetin Beta, in Hematologic Malignancies. Journal of Clinical Oncology. 20(10). 2486–2494. 236 indexed citations

Roschupkina, Teona, Lela Kardava, Darejan Ghirdaladze, et al.. (2000). Impaired phagocytic function of polymorpho-nuclear neutrophils in B chronic lymphocytic leukemia.. WestminsterResearch (University of Westminster).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact